(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -47.69%339.54K | -51.37%435.06K | -51.37%435.06K | -41.41%589.62K | 36.07%606.23K | -13.73%649.11K | -48.16%894.61K | -48.16%894.61K | -54.00%1.01M | -78.70%445.53K |
-Cash and cash equivalents | -47.69%339.54K | -51.37%435.06K | -51.37%435.06K | -41.41%589.62K | 36.07%606.23K | -13.73%649.11K | -48.16%894.61K | -48.16%894.61K | -54.00%1.01M | -78.70%445.53K |
Total current assets | -46.51%358.35K | -51.15%463.11K | -51.15%463.11K | -60.28%612.33K | -35.40%665.8K | -61.94%669.88K | -47.77%947.99K | -47.77%947.99K | -35.56%1.54M | -55.40%1.03M |
Non current assets | ||||||||||
-Long term equity investment | ---- | ---- | ---- | ---- | 0.00%7.12K | --39.34K | --27.79K | --27.79K | 35.82%37.74K | -74.37%7.12K |
-Other intangible assets | -44.32%356.21K | -44.32%356.21K | -44.32%356.21K | -62.44%398.36K | -57.96%445.92K | -41.21%639.77K | -40.38%639.77K | -40.38%639.77K | 12.31%1.06M | 27.70%1.06M |
Regulatory assets | 56.54%11.44K | -47.54%24.28K | -47.54%24.28K | -89.86%16.49K | -38.39%47.35K | -93.00%7.31K | -45.41%46.28K | -45.41%46.28K | 1,047.39%162.69K | 210.54%76.86K |
Total assets | 55.85%11.39K | 18.46%24.23K | 18.46%24.23K | -89.89%16.44K | -86.89%10.07K | -93.00%7.31K | -75.88%20.45K | -75.88%20.45K | 1,047.39%162.69K | 210.54%76.86K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | 0.00%17.58K | -27.58%27.79K | -27.58%27.79K | 0.84%37.74K | --40.33K | 0.00%17.58K | 38.08%38.37K | 38.08%38.37K | 276.00%37.43K | ---- |
-Current capital lease obligation | 0.00%17.58K | -27.58%27.79K | -27.58%27.79K | 0.84%37.74K | --40.33K | 0.00%17.58K | 38.08%38.37K | 38.08%38.37K | 276.00%37.43K | ---- |
-accounts payable | 30.12%67.01K | -82.95%36.45K | -82.95%36.45K | -94.50%37.04K | -98.29%2.44K | -90.30%51.5K | 19.03%213.75K | 19.03%213.75K | 3,443.24%672.9K | 119.54%142.38K |
-Total tax payable | --0 | --0 | --0 | --0 | 0.00%7.12K | 939.04%39.34K | --27.79K | --27.79K | 35.82%37.74K | -74.37%7.12K |
-Due to related parties current | ---- | --0 | --0 | -68.63%101 | --0 | -98.17%943 | -98.79%592 | -98.79%592 | --322 | --0 |
Current accrued expenses | -28.79%8.78K | 0.98%27K | 0.98%27K | --0 | --0 | -53.89%12.33K | 0.00%26.74K | 0.00%26.74K | 0.00%1.74K | 0.00%1.74K |
Current liabilities | 13.38%93.37K | -67.35%91.24K | -67.35%91.24K | -89.49%74.88K | -70.32%42.77K | -86.86%82.35K | -1.23%279.45K | -1.23%279.45K | 1,584.24%712.38K | 67.08%144.11K |
Non current liabilities | ||||||||||
-Long term debt | ---- | --0 | --0 | --0 | 0.00%7.12K | --39.34K | --27.79K | --27.79K | 35.82%37.74K | -74.37%7.12K |
Non current accrued expenses | -5.52%3.84M | -6.09%3.82M | -6.09%3.82M | -6.51%3.77M | -2.83%3.9M | 35.26%4.06M | 51.84%4.07M | 51.84%4.07M | 108.51%4.03M | 84.44%4.01M |
Total non current liabilities | -23.27%93.37K | -70.30%91.24K | -70.30%91.24K | -90.02%74.88K | -67.01%49.89K | -80.70%121.69K | 8.59%307.24K | 8.59%307.24K | 970.31%750.13K | 32.61%151.23K |
Shareholders'equity | ||||||||||
Share capital | 0.00%22.32M | 0.00%22.32M | 0.00%22.32M | 0.03%22.32M | 0.03%22.32M | 4.28%22.32M | 4.33%22.32M | 4.33%22.32M | 5.07%22.31M | 5.07%22.31M |
-common stock | 0.00%22.32M | 0.00%22.32M | 0.00%22.32M | 0.03%22.32M | 0.03%22.32M | 4.28%22.32M | 4.33%22.32M | 4.33%22.32M | 5.07%22.31M | 5.07%22.31M |
Total equity | -11.32%4.2M | -14.60%4.29M | -14.60%4.29M | -21.38%4.38M | -9.49%4.56M | -0.64%4.73M | 11.20%5.02M | 11.20%5.02M | 28.83%5.57M | 12.39%5.04M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.